Accès ouvert
2026
article
OpenAlex
Tamara Stampalija, Claudio Forcato, F. R. Grati, P. Volpe et autres
OBJECTIVE: Pathogenic or likely pathogenic copy-number variants (p/lpCNVs) are a significant cause of perinatal morbidity and mortality. Current prenatal screening based on cell-free DNA (cfDNA) fails to detect the majority of microimbalances (microdeletions/microduplications), leaving a significant residual risk of undetected chromosomal abnormalities. …
it, jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Francesca Romana Grati, Tamara Stampalija, Claudio Forcato, Paolo Volpe et autres
it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Anna Doffini, Claudio Forcato, Chiara Mangano, Debora Lattuada et autres
Introduction: Congenital anemias are a rare genetic cause of nonimmune hydrops fetalis (NIHF).Congenital anemias might be amenable to blood transfusions.Our objective was to review the spectrum of congenital anemias in cases of NIHF diagnosed by exome sequencing (ES).Methods: A systematic review of …
it, sg
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Anna Doffini, Claudio Forcato, Chiara Mangano, Debora Lattuada et autres
OBJECTIVE: To develop a multi-step workflow for the isolation of circulating extravillous trophoblasts (cEVTs) by describing the key steps enabling a semi-automated process, including a proprietary algorithm for fetal cell origin genetic confirmation and copy number variant (CNV) detection. METHODS: Determination of …
it, sg
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Chiara Bolognesi, Claudio Forcato, Genny Buson, Francesca Fontana et autres
Precision medicine in oncology requires an accurate characterization of a tumor molecular profile for patient stratification. Though targeted deep sequencing is an effective tool to detect the presence of somatic sequence variants, a significant number of patient specimens do not meet the …
nl, it
(code pays fourni par la source)
2015
conference-abstract
OpenAlex
Valeria Sero, Francesca De Luca, Anna Doffini, Francesca Galardi et autres
Abstract Background: Little is known about the evolution of genetic aberrations during metastatic cancer progression and in response to systemic treatment. Obtaining repeated tissue biopsies is often impractical. On the other hand, it has been shown that circulating tumor cells (CTCs) can …
it, de
(code pays fourni par la source)
2015
conference-abstract
OpenAlex
Chiara Bolognesi, Anna Doffini, Genny Buson, Rossana Lanzellotto et autres
Abstract Background: We provide a solution of pressing needs in preparation of FFPE samples for genomic analysis: small sample size, unwanted admixture of normal cells, analysis of tumor rare-cell subpopulations present at low percentages in the tumor fraction. Methods: We disaggregated into …
nl
(code pays fourni par la source)
Accès ouvert
2014
article
OpenAlex
Bernhard Michael Polzer, Gianni Medoro, Sophie Pasch, Francesca Fontana et autres
Several hundred clinical trials currently explore the role of circulating tumor cell (CTC) analysis for therapy decisions, but assays are lacking for comprehensive molecular characterization of CTCs with diagnostic precision. We therefore combined a workflow for enrichment and isolation of pure CTCs …
de, it
(code pays fourni par la source)